Considering that CRP has been shown to predict persistent MRSA bacteremia (Chung et al., 2021), these findings further support that a 109 CFU IV dose of MRSA USA 300 is capable of establishing sublethal systemic infections in cynomolgus macaques. This evidence concerns the gene CRP and bacterial infectious disease with sepsis.